Direxion Daily Pharmaceutical & Medical Bull 3X ETF
PILL
4 hedge funds and large institutions have $475K invested in Direxion Daily Pharmaceutical & Medical Bull 3X ETF in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 1 closing their positions.
3,039% more capital invested
Capital invested by funds: $15.1K → $475K (+$460K)
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
33% more funds holding
Funds holding: 3 → 4 (+1)
3.62% more ownership
Funds ownership: 0.1% → 3.72% (+3.6%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$242K |
| 2 |
TRCT
Tower Research Capital (TRC)
New York
|
+$210K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$44.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$11 |
PILL Hedge Fund Activity: Q2 2024 in Review
4 of the 6,925 institutional investors tracked by Wall St. Rank reported a position in Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) for Q2 2024, worth a combined $475K — up 3,039% from $15.1K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new PILL positions and 1 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Susquehanna International Group, opening a new position worth an estimated $242K. The largest seller was Morgan Stanley, exiting entirely with an estimated $11 sold.
- 4 institutional investors held Direxion Daily Pharmaceutical & Medical Bull 3X ETF (PILL) as of Q2 2024, up from 3 in Q1 2024.
- Funds reported $475K of Direxion Daily Pharmaceutical & Medical Bull 3X ETF stock for Q2 2024, up 3,039% quarter-over-quarter.
- 2 funds opened new Direxion Daily Pharmaceutical & Medical Bull 3X ETF positions in Q2 2024 and 1 closed out, a net change of +1 holder.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF buyer in Q2 2024 was Susquehanna International Group, an estimated $242K added.
- The largest Direxion Daily Pharmaceutical & Medical Bull 3X ETF seller in Q2 2024 was Morgan Stanley, an estimated $11 sold.
Based on aggregated 13F filings for Q2 2024.